产品名称
SUPELCOSIL™ LC-18-DB HPLC 色谱柱, 5 μm particle size, L × I.D. 25 cm × 10 mm
Agency
suitable for USP L1
特点
endcapped
制造商/商品名称
SUPELCOSIL™
标记范围
11.0% Carbon loading
参数
0-70 °C temperature
400 bar pressure (5801 psi)
技术
HPLC: suitable
长度 × 内径
25 cm × 10 mm
表面积
170 m2/g
表面覆盖度
surface coverage 3.1 μmol/m2
基质
silica gel, spherical particle platform
基质活性基团
C18 (octadecyl) phase
粒径
5 μm
孔径
120 Å
应用
food and beverages
分离技术
reversed phase
正在寻找类似产品? 访问 产品对比指南
一般描述
SUPELCOSIL LC- DB 类的键合相针对碱性化合物进行了特殊的去活化处理。与其它 A 型硅胶反相色谱柱相比，分析有机碱时该色谱柱保留时间更短、峰形更好和柱效更高。
应用
SUPELCOSIL LC-18-DB HPLC Column has been used for the separation of:
- Analytes of pharmaceutical relevance during their analysis using LC in conjunction with principal component analysis (PCA).
- Uracil in aqueous solutions during its separation by reversed phase high performance liquid chromatography equipped with ultraviolet-visible (UV-Vis) detection.
法律信息
SUPELCOSIL is a trademark of Sigma-Aldrich Co. LLC
法规信息
新产品
此项目有
Characterisation of reversed-phase liquid chromatographic columns by chromatographic tests. Evaluation of 36 test parameters: repeatability, reproducibility and correlation.
Visky D, et al.
Journal of Chromatography A, 977(1), 39-58 (2002)
Ce Li et al.
American journal of physiology. Gastrointestinal and liver physiology, 320(3), G380-G395 (2021-01-28)
Pancreatic ductal adenocarcinoma (PDAC) is highly metastatic and represents one of the deadliest forms of human cancers. Previous studies showed that activation of Yes-associated protein 1 (YAP1) plays a key role in malignant transformation in the pancreas. In this study
Chromatographic classification and comparison of commercially available reversed-phase liquid chromatographic columns using principal component analysis
Euerby MR and Petersson P
Journal of Chromatography A, 994(1-2), 13-36 (2003)
O Majid et al.
Therapeutic drug monitoring, 23(2), 163-168 (2001-04-11)
Recipients of organ transplants remain particularly dependent on prednisolone as part of their maintenance immunosuppression. Despite this, the pharmacokinetics of prednisolone have never been fully characterized in these patients, and consequently dosing remains empirical. Accurate monitoring of prednisolone, its primary
S L Bramer et al.
Journal of pharmaceutical and biomedical analysis, 26(4), 637-650 (2001-08-23)
An LC/MS/MS method for the simultaneous determination of cilostazol, a quinolinone derivative, and three active metabolites, OPC-13015, OPC-13213, and OPC-13217, in human plasma was developed and validated. Cilostazol, its metabolites, and the internal standard, OPC-3930 were extracted from human plasma
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持